HealthPartners programs designed to improve the quality and efficiency of care reduced medical expenses by $99.7 million in 2008. The group of health care companies, which serves over a million US medical and dental health plan members, says that decision support for diagnostic imaging reduced unnecessary tests by more than $5.8 million, an 80% increase over last year's savings. The program provides physicians with the latest guidelines from the American College of Radiology to confirm that a test is appropriate. Meanwhile, a program to encourage generic drug use resulted in HealthPartners' members saving $64.4 million, more than double that saved in 2007.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze